Subcutaneous low-molecular-weight heparin (LMWH) versus warfarin sodium (WS) for prophylaxis of deep-vein thrombosis (DVT) after total hip or total knee replacement (THR/TKR): An economic perspective Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hull, RD
  • Raskob, GE
  • Pineo, GF
  • Feldstein, W
  • Rosenbloom, D
  • Gafni, Amiram Jacob
  • Green, D
  • Feinglass, J
  • Trowbridge, A
  • Elliott, CG
  • Lerner, R
  • Brant, RF

publication date

  • June 1, 1997